SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias (Spatax)
Clinical and Genetic Analysis of Autosomal Recessive Forms of Cerebellar Ataxias and Spastic Paraplegias
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
This observational or N/A phase trial investigates Cerebellar Ataxias and Spastic Paraplegias and is currently completed. Institut National de la Santé Et de la Recherche Médicale, France leads this study, which shows 8 recorded versions since 2004 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Mar 2025 — Sep 2025 [monthly]
Completed
Status: Unknown → Completed
-
Sep 2024 — Mar 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status
-
Apr 2018 — Jun 2018 [monthly]
Unknown Status
Phase: PHASE1 → None
-
Jan 2017 — Apr 2018 [monthly]
Unknown Status PHASE1
First recorded
Feb 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Institut National de la Santé Et de la Recherche Médicale, France
- Institut des Maladies Rares
- National Research Agency, France
- Paris Brain Institute (ICM)
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Algiers, Algeria , Angers, France , Beirut, Lebanon , Belgrade, Serbia , Bordeaux, France , Brussels, Belgium , Clermont-Ferrand, France , Copenhagen, Denmark , Grenoble, France , Jerusalem, Israel and 15 more locations